glp 1 agonist drugs side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Long-Term Effects Of GLP-1 Medications:

Description

When appetite drops dramatically, many people naturally reduce protein intake, which can lead to muscle loss alongside fat loss

Around 20-25% of the weight lost on retatrutide is muscle and bone rather than fat, similar to other drugs in this family

doi: 10.1002/cne.902710405

doi: 10.1016/j.diabres.2022.109806

Between 1969 and 1971, work by John Brown and Raymond Pederson, together with the peptide chemistry expertise of Erik Jorpes and Viktor Mutt [67], led to the identification of the gastric inhibitory polypeptide (GIP), a 42-amino acid polypeptide that was named based on its potency to suppress gastric motility and gastric acid secretion [[68], [69], [70]]